Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects (2021)
- Authors:
- Autor USP: RONSEIN, GRAZIELLA ELIZA - IQ
- Unidade: IQ
- DOI: 10.1161/ATVBAHA.121.316278
- Subjects: ESTATINAS; LIPOPROTEÍNAS HDL; PROTEÔMICA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título do periódico: Arteriosclerosis, Thrombosis, and Vascular Biology
- ISSN: 1079-5642
- Volume/Número/Paginação/Ano: v. 41, p. 2330–2341, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
RONSEIN, Graziella Eliza et al. Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, v. 41, p. 2330–2341, 2021Tradução . . Disponível em: https://doi.org/10.1161/ATVBAHA.121.316278. Acesso em: 15 maio 2024. -
APA
Ronsein, G. E., Vaisar, T., Davidson, W. S., Bornfeldt, K. E., Probstfield, J. L., O’Brien, K. D., et al. (2021). Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 41, 2330–2341. doi:10.1161/ATVBAHA.121.316278 -
NLM
Ronsein GE, Vaisar T, Davidson WS, Bornfeldt KE, Probstfield JL, O’Brien KD, Zhao X-Q, Heinecke JW. Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects [Internet]. Arteriosclerosis, Thrombosis, and Vascular Biology. 2021 ; 41 2330–2341.[citado 2024 maio 15 ] Available from: https://doi.org/10.1161/ATVBAHA.121.316278 -
Vancouver
Ronsein GE, Vaisar T, Davidson WS, Bornfeldt KE, Probstfield JL, O’Brien KD, Zhao X-Q, Heinecke JW. Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects [Internet]. Arteriosclerosis, Thrombosis, and Vascular Biology. 2021 ; 41 2330–2341.[citado 2024 maio 15 ] Available from: https://doi.org/10.1161/ATVBAHA.121.316278 - Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
- Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
- Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles
- Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
- Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration
- Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone
- Time to ditch HOL-C as a measure of PINION HOL function?
- Inflammation, remodeling, and other factors affecting HDL cholesterol efflux
- Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients
- Oxidação do triptofano pelo oxigenio molecular no estado singlete [´OIND.2´(´ANTPOT.1´DELTA IND.g´)]: estudos mecanisticos envolvendo marcação isotopica, espectrometria de massa e quimiluminescencia
Informações sobre o DOI: 10.1161/ATVBAHA.121.316278 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
